Morgan Stanley Artivion, Inc. Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
A detailed history of Morgan Stanley transactions in Artivion, Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,450,575 shares of AORT stock, worth $74.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,450,575
Previous 2,360,518
3.82%
Holding current value
$74.1 Million
Previous $60.5 Million
7.74%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding AORT
# of Institutions
174Shares Held
35.8MCall Options Held
33KPut Options Held
900-
Black Rock Inc. New York, NY6.64MShares$201 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$84.7 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$84.5 Million1.94% of portfolio
-
Macquarie Group LTD Australia, C32.75MShares$83 Million0.08% of portfolio
-
Juniper Investment Company, LLC New York, NY2.1MShares$63.4 Million22.69% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.22B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...